This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

 
 

News

  • Adjuvant immunotherapy after melanoma surgery reduces risk of cancer recurrence

    In melanoma patients who are also treated with the immune therapy pembrolizumab after surgery, the risk of recurrence of the disease is almost twice as small as in patients who receive a placebo. This was shown by a randomized study in 23 countries, of more than 1000 melanoma patients, of whom 50 were from the Netherlands Cancer Institute.

    Read More
  • Anastassis Perrakis appointed Professor of Macromolecular Structures at Utrecht University

    Biochemist Anastassis (Tassos) Perrakis has been appointed Endowed Professor of Macromolecular Structures at Utrecht University. Perrakis is a researcher and group leader at the Netherlands Cancer Institute and an expert in unravelling cancer proteins.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us